EDGAR Filing Documents for 0001140361-14-031227

Form 4 - Statement of changes in beneficial ownership of securities:

SEC Accession No. 0001140361-14-031227

Filing Date

2014-08-07

Accepted

2014-08-07 15:07:07

Documents

Period of Report

2014-08-05

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 4	doc1.html	4
1	FORM 4	doc1.xml	4	38851
	Complete submission text file	0001140361-14-031227.txt		40251

Mailing Address 1035 O?BRIEN DRIVE, SUITE A MENLO PARK CA 94025

Business Address 1035 O?BRIEN DRIVE, SUITE A MENLO PARK CA 94025 650-272-6269

Avalanche Biotechnologies, Inc. (Issuer) CIK: 0001501756 (see all company filings)

IRS No.: 205258327 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O AVALANCHE BIOTECHNOLOGIES, INC. 1035 O'BRIEN DRIVE, SUITE A MENLO PARK CA 94025

Business Address

Type: 4 | Act: 34 | File No.: 001-36579 | Film No.: 141023444